Sanofi (SAN.FR) Stock Price, Financials & Summary

Key data

Open—

From 52W high—

Volume—

Market cap—

P/E (TTM)—

P/S (TTM)—

Div yield—

Key data

Open

—

From 52W high

—

Volume

—

Market cap

—

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

—

MomentumView details →

1D Return

—

YTD Return

—

SummaryUpdated Jun 1, 2026

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company founded in 1973 and headquartered in Paris, France. Originally known as Sanofi-Aventis until 2011, the company has evolved into one of the world's largest pharmaceutical companies through strategic acquisitions and organic growth. Sanofi operates as a diversified healthcare company with a focus on innovative medicines, vaccines, and consumer health products, serving patients across more than 170 countries worldwide.

Ask drillr about Sanofi →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

—

YTD Return

—

1Y Return

—

RSI (14)

—

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

48.92B

Net Income (TTM)

3.96B

Op. CF (TTM)

14.29B

Latest newsMore news →

Bavarian Nordic A/S appointed Tarja Stenvall as President and Chief Executive Officer effective October 15, 2026, succeeding Paul Chaplin.3d ago

Sanofi announced a C$925 million investment in Canada, including C$415 million in partnership funding from the Canadian government and C$55 million from the Ontario provincial government.4d ago

Latest newsMore news →

Bavarian Nordic A/S appointed Tarja Stenvall as President and Chief Executive Officer effective October 15, 2026, succeeding Paul Chaplin.3d ago Sanofi announced a C$925 million investment in Canada, including C$415 million in partnership funding from the Canadian government and C$55 million from the Ontario provincial government.4d ago Sanofi's C$925 million influenza vaccine manufacturing facility in Toronto began production.4d ago